ACTG vs MRNA · rev $168.8M vs rev $145.0M
Acacia Research Corporation (ACTG) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Acacia Research Corporation (ACTG) is a business equipment & supplies company listed on NASDAQ.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported ACTG revenue for 2026-06-30 was $168.8M. Net income was -$15.7M. ACTG currently screens at market cap $452.0M.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
ACTG currently screens at market cap $452.0M. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the ACTG and MRNA stock pages for the full models.
Not investment advice.